PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 26: Articles 12501-13000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Family planning. [Planiranje obitelji.]
  2. Family planning. Objectives, measures, regulations, structures. [Planification familiale: objectifs, moyens, reglementation, structures.]
  3. Family planning: a controversial conception.
  4. Family planning: a necessity in primary care. [Planificacion familiar: una necesidad en atencion primaria.]
  5. Family-planning risk-scoring system: updated.
  6. Fatal course of hepatic peliosis with possible linkage to oral contraception. [Todlicher Verlauf einer Peliosis hepatis mit moglicher Beziehung zur oralen Kontrazeption.]
  7. Favorable effects of oral estrogen-progestin contraception. [Priznive pusobeni oralni estrogen-progestinove kontracepce.]
  8. Fear of contraceptives, wish for closer relationship are major reasons teenagers delay visiting clinic.
  9. Female contraception and male fertility regulation.
  10. Fertility and contraceptive use among young adults in Harare, Zimbabwe.
  11. Fertility and family planning in Vietnam.
  12. Fertility and family planning, Kinshasa, 1988. [Fecondite et planification familiale, Kinshasa, 1988.]
  13. The fertility impact of contraceptive use in Egypt: an aggregate analysis.
  14. Fertility intentions and access to services as constraints on contraceptive use in Colombia.
  15. Fetal loss and contraceptive acceptance among the Bhopal gas victims.
  16. Fetal outcome among pregnancies in natural family planning acceptors: an international cohort study.
  17. Final report of an operations research project: "A Study to Increase the Availability and Price of Oral Contraceptives in Three Program Settings", Contract CI90.59A.
  18. Final report on Operation Research for an Effective Information and Education Approach for Family Planning.
  19. Final report. The Upazila Initiatives Project: September 1987 - December 1990. Strengthening local family planning program management in Bangladesh by applying lessons learned in Indonesia.
  20. Final report. Visual Literacy Bangladesh Project AS-BAN-03. A study undertaken by the Johns Hopkins University Population Communication Services and conducted by the Program for the Introduction and Adaptation of Contraceptive Technology, Bangladesh. Project duration: February 9, 1988 - March 31, 1989.
  21. Final report: Project for Contraception Information and Services in Kananga, November 1987 - December 1990. [Rapport final: Projet pour Services et Information sur la Contraception a Kananga, Novembre 1987 - Decembre 1990.]
  22. Final report: Television and Family Planning Practices in Urban Nigeria II: the National Television Authority / Ibadan Experience. Projects AF-NGA-12 and 23.
  23. Final report: Using Photonovels to Promote Family Planning Awareness, Project AF-NGA-16.
  24. Financing family planning services: is categorical legislation still needed?
  25. Five keys to progress in family planning.
  26. Five levels of family planning progress: lessons from Thailand.
  27. Folic acid and vitamin deficiency caused by oral contraceptives. [Folsaure- und Vitaminmangel durch orale Kontrazeptiva.]
  28. Follow-up checks on liver alterations due to steroid contraceptives. [Verlaufsuntersuchung uber Leberveranderungen infolge steroidaler Kontrazeptiva.]
  29. Follow-up of adolescent oral contraceptive users.
  30. Food and Drug Administration: birth control implant approved.
  31. Frequency and severity of premenstrual symptoms in women taking birth control pills.
  32. From abortion to contraception in Romania.
  33. From Abortion to Contraception, Tbilisi, 10-13 October 1990. Conference report.
  34. From abortion to contraception: Tbilisi, 1990.
  35. From policy to norms to services: developing a consensus for natural family planning.
  36. Frontiers in nonhormonal male contraceptive research.
  37. Further analysis of contraceptive failure of the ovulation method.
  38. The future of hormonal contraception.
  39. Future UNFPA support for the introduction of Norplant and Norplant II subdermal implants into national family planning programmes (1992-1995)
  40. Gaining policy support for natural family planning.
  41. Gap between reproductive preferences and contraceptive practice. [Brecha entre preferencias reproductivas y practica anticonceptiva.]
  42. Gender differences in reproductive orientation in Ghana: a new approach to understanding fertility and family planning issues in sub-Saharan Africa.
  43. General Secretary Jiang Zemin and Premier Li Peng on family planning.
  44. Geographic tongue during a year of oral contraceptive cycles.
  45. Government and society in Southeast Asian family planning programs: the cases of Indonesia, Viet Nam and the Philippines.
  46. GTZ -- working for health in Africa. The need for family planning.
  47. Guidance on use of contraceptive methods. What contraceptive method should be used? [Radgivning om anvendelsen af svangerskabsforebyggende metoder. Hvilken kontraceptiv metode skal benyttes?]
  48. Guide to conducting cost / savings analyses of private sector family planning programs.
  49. A guide to methods of birth control.
  50. Guidelines on improving delivery and evaluation of population and family planning programmes in African countries.
  51. Incorporating family planning services into a self-financed health model in rural Guatemala.
  52. Increasing contraceptive use in Bangladesh: the role of demand and supply factors.
  53. Increasing the application of operations research findings in public sector family planning programs: lessons from the ICDDR,B Extension Project.
  54. India launches the new weekly contraceptive pill.
  55. India: accessibility of contraceptives.
  56. Indications and contraindications for prescribing oral contraceptives. [Indikationsgerechte Verordnung hormonaler Kontrazeptiva.]
  57. Indonesia family planning aims for sustainability.
  58. Indonesia: accessibility of contraceptives.
  59. The Indonesian family planning program: an economic perspective.
  60. Induced abortion and contraception in Italy.
  61. Infection prevention guidelines for family planning service programs.
  62. Influence of contraceptives on vaginal ecology and infections.
  63. The influence of different modern low-dose oral contraceptives on intermenstrual bleeding.
  64. The influence of economics and culture on the family planning policies of the People's Republic of China.
  65. Influence of family planning programs on transition to motherhood among women in Shifang county, Sichuan, China.
  66. Influence of oral contraceptives on body temperature [letter]
  67. Information for users -- contraceptive services [editorial]
  68. Information, education and communication in family planning project for north-central Ivory Coast. Final report on preliminary focus group research. [Projet d'information, d'education et de communication en planification familiale pour la region du centre-nord de la Cote d'Ivoire. Rapport final des recherches preliminaires sur les publics.]
  69. Information, education and communication on family planning and maternal and child health care: an evaluation of a special action programme in northern Karnataka.
  70. Information, education, communication and motivation (IECM) strategy and master plan for the Philippine Family Planning Program (PFPP), 1992-1994. Final draft for discussion.
  71. An informed choice ensures peace of mind. Contraceptive counselling in the community.
  72. Inhibition of antipyrine metabolism by low-dose contraceptives with gestodene and desogestrel.
  73. An initial assessment of communication research needs for family planning communication in the Philippines.
  74. The initiation of contraceptive use in the People's Republic of China.
  75. Innovative approaches from Population Communication Services: implications for natural family planning.
  76. Institute for International Studies in Natural Family Planning: technical progress report, October 1, 1990 - March 31, 1991, Cooperative Agreement DPE-3040-A-00-5064-00.
  77. Institutionalization of family planning service delivery personnel training: a manpower development tool.
  78. Institutionalizing family planning research in Nigeria.
  79. Integrated maternal and child health and family planning.
  80. Integrated programs in family planning: the East Java experience.
  81. Integration of family planning activities with the Community Development Program.
  82. Integration of family planning program.
  83. The integration of IEC into family planning programs: lessons applicable to operations research.
  84. Interactions between oral contraceptives and other medications. [Interaktioner mellem orale kontraceptiva og andre laegemidler.]
  85. Interactions between oral contraceptives and therapeutic drugs. [Interactions entre les contraceptifs oraux et les medicaments therapeutiques.]
  86. Interchangeability of oral contraceptive products [letter]
  87. Interchangeability of oral contraceptive products.
  88. International family planning: where's the leadership?
  89. International Planned Parenthood Federation's policy and support for periodic abstinence: rationale and future plans.
  90. International Planned Parenthood Federation. Annual report 1990-91. Sowing the seeds of change.
  91. Interpersonal communication and counseling for family planning. Nigeria. Three-day curriculum.
  92. Interruption of pregnancy: motives, attitudes and contraceptive use. Interviews before abortion, at a family planning clinic, Rome.
  93. Intrauterine contraception in nulliparous women. [Vnutrimatochnaia kontratseptsiia u nerozhavshikh zhenshchin.]
  94. Intrauterine contraception today [editorial]
  95. Intrauterine contraception. 5th ed.
  96. Intrauterine contraception. 5th ed.
  97. The intrauterine contraceptive device, "Multiload Cu 250": a regulatory problem.
  98. Intrauterine contraceptive devices with missing tails (lost coils)
  99. Introduction and overview of natural family planning training programs.
  100. Introduction of natural family planning information into multimethod materials for trainers.
  101. Introduction. Natural Family Planning: Current Knowledge and New Strategies for the 1990s. Proceedings of a conference, Georgetown University, Washington, D.C., December 10-14, 1990.
  102. Introduction: commitment to natural family planning and the need for action.
  103. An investigation of the influence of expectancy on affective and physical changes associated with oral contraceptive use.
  104. Invited commentary: the contraceptive technology tightrope.
  105. Is anti-abortion movement undermining contraception?
  106. Is the Bellagio consensus statement on the use of contraception sound public-health policy?
  107. Is the lactational amenorrhea method a part of natural family planning? Biology and policy.
  108. Is there a role for family planning in responding to AIDS?
  109. Issues in private sector family planning: the experience of the Enterprise Program.
  110. Japan to lift ban on oral contraception.
  111. A joint model of contraceptive choice and frequency of intercourse: implications for estimates of contraceptive use-failure.
  112. Journey to the world of contraception: a guide to contraceptive methods. [Viagem ao mundo da contracepcao: um guia sobre os metodos anticoncepcionais.]
  113. The KAP-gap and the unmet need for contraception.
  114. The KAP-gap in Nepal: reasons for non-use of contraception among couples with an unmet need for family planning.
  115. Kenya: many women know about contraceptives, but few use them.
  116. Knowledge and practice of family planning in Ongole Taluk of Prakasam district in Andhra Pradesh.
  117. Knowledge and use of contraception.
  118. Knowledge and use of contraceptive methods on the Atlantic coast of Colombia. [Conocimiento y uso de metodos anticonceptivos en la Costa Atlantica Colombiana.]
  119. Knowledge and use of the contraceptive effect of breastfeeding: evidence from Malaysia.
  120. Knowledge of breastfeeding and family planning among men and women in Indonesia.
  121. Knowledge regarding family planning methods among rural women of Faridkot district of Punjab.
  122. Knowledge, attitude and behaviour of students towards family planning in Kenya.
  123. Lack of effect of oral contraceptive use on the pharmacokinetics of quinine.
  124. A lack of knowledge. An investigation of the social and contraceptive behavior of young Russian married couples.
  125. Lessons from Narangwal about primary health care, family planning and nutrition.
  126. Lessons learned: September 15, 1984 - September 14, 1990. INOPAL I. Final technical report: Operations Research to Improve Family Planning and Maternal-Child Health Service Delivery Systems in Latin America and the Caribbean (USAID Cont. Num. DPE-3030-C-00-4074-00). Volume I. Operations research findings, impacts, and lessons learned in project development.
  127. Levels of serum steroid hormones in intrauterine contraceptive device users.
  128. Levonorgestrel subdermal implants (Norplant) for long-term contraception.
  129. Limited access. Contraceptive costs may impede use.
  130. Literature review on family planning beliefs, attitudes and behaviour and consumer exposure to radio, film, print and traditional media and interpersonal communication in Tanzania.
  131. Long-acting hormonal contraceptives for women.
  132. Long-acting steroid contraceptive technology.
  133. Looking at abortion and contraception.
  134. Low dose oral contraceptive in Bangladesh: a study on acceptability and switching from standard to low dose. Summary.
  135. Main points for 1991 family planning work.
  136. Making family planning more effective -- Papua New Guinean style [editorial]
  137. Male attitudes toward family planning.
  138. Male contraception. [Kontratseptsiia u muzhchin.]
  139. Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives.
  140. Malthus, malthusianism, family planning and ONAPO. [Malthus, le malthusianisme, le planning familial et l'ONAPO.]
  141. Management information systems in maternal and child health / family planning programs: a multi-country analysis.
  142. A management needs assessment for African natural family planning programs: process and results.
  143. Management of family planning programs and operations research.
  144. Managing external collaboration in family planning.
  145. Manifest and latent unmet need for family planning in Indonesia.
  146. Manual on Islam and family planning.
  147. Marital power structure, fertility and family planning in India.
  148. Market-based family planning: lessons from the Enterprise experience.
  149. Mass media and family planning campaigns. Experiences from past, present, outlooks for tomorrow. Male motivation campaign: the Zimbabwean experience.
  150. Maternal and child health / family planning: 1991 annual report.
  151. Maximizing oral contraceptive effectiveness: a clinician's handbook.
  152. Measuring contraceptive use-failure and continuation: an overview of new approaches.
  153. Measuring contraceptive values: an alternative approach.
  154. Measuring natural family planning in terms of couple-years of protection.
  155. Measuring the dynamics of contraceptive use. Proceedings of the United Nations Expert Group Meeting on Measuring the Dynamics of Contraceptive Use, New York, 5-7 December 1988.
  156. Measuring the influence of accessibility of family planning services in developing countries. Summary of an expert meeting.
  157. Mechanism of action of progesterone as contraceptive for lactating women.
  158. Meeting the future. Where will the resources for the USSR's family planning programs come from?
  159. Memoir -- the beginning of oral contraceptives.
  160. Men and family planning: a special initiative.
  161. Men's involvement in family planning and vasectomy initiatives. Report of a planning workshop held in Nairobi, Kenya, November 14-16, 1990.
  162. The mentally handicapped and contraception. [Deficientes mentais e contracepcao.]
  163. Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in culture.
  164. Methodological pitfalls in the analysis of contraceptive failure.
  165. Methods of birth control in Eastern Europe. [Les modes de prevention des naissances en Europe de l'Est.]
  166. Mexico: a decade of family planning and contraceptive practice. [Mexico: una decada de planificacion familiar y practica anticonceptiva.]
  167. Midterm evaluation of family planning self-reliance projects, Costa Rica.
  168. Midterm evaluation of the Bangladesh Family Planning and Health Services Delivery Project (388-0071)
  169. Migraine and oral contraception. [Migraine et contraception orale.]
  170. Minister Peng inspects family planning work in Shandong.
  171. Missing intrauterine contraceptive device presenting with strings at the anus.
  172. A model for employer-financed family planning and health services: a case study of Atma Jaya hospital, Jakarta. Study period: January, 1988 - September, 1990. Final report.
  173. Modelling the impact on mortality of the use of combined oral contraceptives.
  174. Mood changes during the menstrual cycle and their relation to the use of oral contraceptive.
  175. The morning after pill. Post-coital contraception. [La pilule du lendemain. Contraception post-coitale.]
  176. Morphofunctional features of the cervix uteri in women using hormonal contraception. [Morfofunktsionalnye osobennosti sheiki matki u zhenshchin, primenialiushchikh gormonalnuiu kontratseptsiiu.]
  177. Most Zimbabwean men approve of family planning, but believe it should wait until after the first birth.
  178. A multicentre study of coagulation and haemostatic variables during oral contraception: variations with geographical location and ethnicity.
  179. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
  180. The Muslims and family planning.
  181. Mutual complementarity of nutrition and family planning for safe motherhood: the synergistic role of breastfeeding.
  182. National Sample Survey of Fertility and Contraception. Technical Documents.
  183. Natural contraceptive methods.
  184. The natural family planning - lactational amenorrhea method interface: observations from a prospective study of breastfeeding users of natural family planning.
  185. Natural family planning and sex selection: fact or fiction?
  186. Natural family planning in a family planning program.
  187. Natural family planning program format effectiveness.
  188. Natural family planning through the health sector in Brazil.
  189. Natural family planning through the health sector in India.
  190. Natural family planning use in Peru.
  191. Natural family planning use-effectiveness and continuation.
  192. Natural family planning: current knowledge and new strategies for the 1990s. Proceedings of a conference.
  193. Natural family planning: looking ahead.
  194. Natural family planning: national program development in Kenya.
  195. Natural family planning: point, counterpoint.
  196. Natural family planning: time for change in attitude [editorial]
  197. Natural family planning: US Agency for International Development policy considerations.
  198. A natural setting for personal advice. Setting up a GP practice family planning clinic.
  199. The nature of demand for contraceptive service: implications for family planning programmes in Pakistan.
  200. Necessity of family planning among the nationalities in view of the population structure in the Hui minority in Ningxia.
  201. The necessity of family planning policy.
  202. The need for family planning services for women with little or no prenatal care.
  203. Neoplastic effects of oral contraceptives.
  204. A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive.
  205. New approaches to expanding natural family planning.
  206. New developments in contraceptive technology.
  207. A new method for estimating contraceptive failure rates.
  208. New thinking in contraception.
  209. News coverage of population and family planning efforts of India between 1951 and 1990 as reported in the "New York Times": a content analysis.
  210. NGO / government collaboration in maternal health and family planning programs: summary of key findings.
  211. Nigeria. Family planning and population control. "How big is too big"?
  212. The Nigerian national family planning logo project.
  213. Non-smoking women, regardless of age, may use modern oral contraceptives. [Icke-rokande kvinnor kan oberoende av alder anvanda moderna p-piller.]
  214. Nonbarrier contraceptives and vaginitis and vaginosis.
  215. Norminest in Egypt: comparing the CSM brand to other oral contraceptives.
  216. The Norplant system of contraception.
  217. Norplant: a new contraceptive.
  218. North-Central Region Family Planning Information Project. Final report on preliminary audience research.
  219. Nursing students' attitudes towards abortion and family planning in Italy and Sweden.
  220. Observations in vivo on spermicidal effect of nonoxynol-9 contraceptive in forms of effervescent suppository and film.
  221. On the integration of fighting poverty with family planning work.
  222. On the slow lane. Family planning campaign now catches on in Nigeria.
  223. On the socioeconomic benefits of family planning work.
  224. Operations research findings in Latin America and the Caribbean: implications for family planning program managers.
  225. Operations research for quickly evaluating the quality of interpersonal exchanges in a family planning clinic.
  226. Operations research on family planning logistics distribution.
  227. Operations research on the distribution of family planning commodities and IEC materials.
  228. An operations research study of clinic performance in the Philippine Family Planning Program.
  229. Operations research: helping family planning programs work better. Report of the MORE Conference and Workshop.
  230. Oral contraception and benign breast disease. [Contraception orale et mastopathies benignes.]
  231. Oral contraception and benign breast disease: the epidemiologist's perspective. [Contraception orale et mastopathies benignes: le point de vue de l'epidemiologiste.]

     

  232. Oral contraception and drug interactions. [Contraception orale et interactions medicamenteuses.]
  233. Oral contraception and its possible protection against rheumatoid arthritis.
  234. Oral contraception in the perimenopause.
  235. Oral contraception: a review.
  236. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast.
  237. Oral contraceptive agents and blood lipid levels. [Pille und Lipidspiegel.]
  238. Oral contraceptive compliance and continuation in Egypt: complementary findings of EDHS (1988) and focus group research.
  239. Oral contraceptive compliance and its role in the effectiveness of the method.
  240. Oral contraceptive drug interactions: important considerations.
  241. Oral contraceptive steroids -- pharmacological issues of interest to the prescribing physician.
  242. Oral contraceptive use and coronary risk factors in women.
  243. Oral contraceptive use and gestational choriocarcinoma.
  244. Oral contraceptive use and the incidence of cervical intraepithelial neoplasia.
  245. Oral contraceptive use and the risk of ovarian cancer: an Italian case-control study.
  246. Oral contraceptive use may protect against low bone mass.
  247. Oral contraceptive use, caffeine consumption, field-dependence, and the discrimination of colors.
  248. Oral contraceptive-induced esophageal ulcer. Two cases and literature review.
  249. Oral contraceptive-induced lupus erythematosus in a Japanese woman.
  250. Oral contraceptives and antibiotics in acne [letter]
  251. Oral contraceptives and breast cancer. A meta-analysis.
  252. Oral contraceptives and breast cancer: analysis of the statistical power of the association. [Anticonceptivos orales y cancer de mama: analisis de la potencia estadistica de la asociacion.]
  253. Oral contraceptives and breast cancer: review of the epidemiologic literature.
  254. Oral contraceptives and breast disease.
  255. Oral contraceptives and cancer.
  256. Oral contraceptives and cervical cancer. Analysis of the strength of the association. [Contraconceptivos orales y cancer de cuello uterino. Analisis del poder de la asociacion.]
  257. Oral contraceptives and coronary heart disease.
  258. Oral contraceptives and diabetes mellitus.
  259. Oral contraceptives and early-term abortifacients during classical antiquity and the Middle Ages.
  260. Oral contraceptives and neoplasia: an introduction.
  261. Oral contraceptives and skin neoplasia.
  262. Oral contraceptives and the risk of endometrial cancer.
  263. Oral contraceptives as risk factors for vascular disease: what is known about the molecular mechanism? [Die Antibaby-Pille als Risikofaktor einer Thrombose: Sind molekulare Mechanismen bekannt?]
  264. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
  265. Oral contraceptives for women over the age of 35.
  266. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.
  267. Oral contraceptives in the immediate postpartum period.
  268. Oral contraceptives in the puerperium.
  269. Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats.
  270. Oral contraceptives, androgens, and the sexuality of young women: I. A comparison of sexual experience, sexual attitudes, and gender role in oral contraceptive users and nonusers.
  271. Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens.
  272. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
  273. ORG surveys of family planning practices in India: a statistical review.
  274. Organizations involved in family planning program.
  275. Ortho study reveals women's contraceptive preferences.
  276. The outlook for the development of contraception. [Perspektivy razvitiia kontratseptsii.]
  277. Outreach to women at high risk of perinatal HIV transmission presents new challenges to family planning providers.
  278. Overview and summary: the interface of breastfeeding, natural family planning, and the lactational amenorrhea method.
  279. An overview of national family planning program.
  280. Overview of social science and behavioral issues in natural family planning.
  281. Overview of the management development in the National Family Planning Program.
  282. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk.
  283. Oxytocin, somatostatin, insulin and gastrin concentrations vis-a-vis late pregnancy, breastfeeding and oral contraceptives.
  284. The Pakistan family planning program: a launch country case study. Characteristics of a launch country.
  285. Pakistan's renewed commitment to family planning.
  286. Pancreatitis and oral contraception. Answer to question. [Pancreatite et contraception orale.]
  287. Patterns and perceptions of family planning methods: findings from focus group discussions in Egypt.
  288. Patterns of contraceptive use among urban women in Taiwan.
  289. Patterns of contraceptive use in the United States: the importance of religious factors.
  290. Perceptions of vulnerability to pregnancy and the use of effective contraception.
  291. Perimarital counselling on family planning.
  292. Peritoneal response to a copper-bearing intrauterine contraceptive device: an experimental study in rats.
  293. Perspectives of application of monoclonal antibody drug conjugate to family planning.
  294. Perspectives. The U.S. contraceptive gap.
  295. Pharmacokinetics of levonorgestrel in 18 women after 1 month of treatment with a triphasic oral contraceptive.
  296. Pharmacokinetics of synthetic sex steroids in hormonal contraceptives. [Pharmakokinetik synthetischer Sexualsteroide in hormonalen Kontrazeptiva.]
  297. Philippines: accessibility of contraceptives.
  298. A pilot study on teaching natural family planning in general practice.
  299. Planned Parenthood Ass'n v. Miller [17 June 1991]
  300. Planned Parenthood of Southeastern Pennsylvania v. Casey [21 October 1991]
  301. Planning your family. [Flipchart] [Pour planifier votre famille.]
  302. Poland: abortion and contraception.
  303. Policies and support for natural family planning: rationale and future plans.
  304. The policy and program role of family planning NGOs in strengthening national infrastructure.
  305. Polish family planning in crisis: the Roman Catholic influence.
  306. Political and practical issues in the implementation of operations research studies in natural family planning.
  307. Political constraints on contraceptive development in the United States.
  308. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use.
  309. Pop wins over Nigerians to family planning.
  310. [Population and family planning in Tunisia: an educational reference in the fields of population education, family health and family planning]
  311. Population change and family planning from the perspectives of women in Asia and the Pacific.
  312. Population estimates and contraceptive requirements for Sri Lanka 1991-2001.
  313. Population picks and pans. The Population Crisis Committee's 1991 selection of the ten countries worldwide making the most and least progress in family planning.
  314. Post-partum family planning in Honduras.
  315. Postcoital contraception [letter]
  316. Postcoital contraception: myth or reality?
  317. Postpartum contraception: perspectives from clients and providers in six countries.
  318. Pre-project evaluation of a government based international family planning co-operative project -- from a survey at project site in Colombia.
  319. Preconception counseling and contraception after gestational diabetes.
  320. Prescribing oral contraceptives and the medical record.
  321. Prevalence of HPV cervical infection in a family planning clinic determined by polymerase chain reaction and dot blot hybridisation.
  322. Prevalence of smoking and oral contraception in a sample of Danish young women.
  323. Preventing pregnancy, protecting health: a new look at birth control choices in the United States.
  324. Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III Von Willebrand disease and afibrinogenemia. Case reports.
  325. Private sector family planning: Ghana's midwives deliver.
  326. Production of family planning informational booklet, September 1, 1991 to November 30, 1991, JHU / PCS Letter of Agreement No. NE-YEM-01.
  327. The Profamilia family planning program, Colombia: an economic perspective.
  328. Profile: the National Documentation Centre for Family Planning of India's National Institute of Health and Family Welfare.
  329. Progestin-only contraception.
  330. The program of the Institute for International Studies in Natural Family Planning.
  331. Prolonged risk of streptococcal peritonitis associated with an intrauterine contraceptive device.
  332. Promoting family planning: findings from operations research and program research.
  333. The promotion of family planning by financial payments: the case of Bangladesh.
  334. Propaganda work is still a weak link in rural family planning.
  335. Prospects for increased contraceptive pill use in Japan.
  336. Protective role of lipanthyl in women taking oral contraceptives.
  337. Providing effective management assistance: six keys to working with family planning organizations in developing countries.
  338. Providing family planning: the private sector experience.
  339. Providing NFP counseling within a family planning clinic.
  340. Proximity to contraceptive services and fertility transition in rural Kenya.
  341. Psychographic profiles lead to family planning communication intervention in rural Mexico.
  342. Psychological profiles of family planning clients and non-clients. RI/1386. Report on main findings.
  343. Psychosexual aspects of natural family planning as revealed in the World Health Organization multicenter trial of the ovulation method and the New Zealand Continuation Study.
  344. Psychosocial factors in natural family planning: an overview.
  345. Psychosomatic aspects of oral contraception. [Psychosomatische Aspekte der oralen Kontrazeption.]
  346. Qualitative methods in operations research on contraceptive distribution systems: a case study from Nigeria.
  347. Quality of care in commercial and social marketing of family planning programs in Latin America and the Caribbean. [La calidad de atencion en el mercadeo comercial y social de los programas de planificacion familiar en America Latina y el Caribe.]
  348. Quality of care in contraceptive social marketing.
  349. Quality of care in postpartum contraception.
  350. Quality of family planning services in Latin America: regional overview.
  351. The quality of family planning services in the Mexican Social Security Institute.
  352. A racial and ethnic comparison of family formation and contraceptive practices among low-income women.
  353. Re: "Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease" [letter]
  354. Reaching new populations with natural family planning education.
  355. Reaching urban women with family planning services in Ahmedabad, India. Special study.
  356. Reagan's federalism and family planning services: implications for family policy.
  357. Reasons for delay in contraceptive clinic utilization: adolescent clinic and nonclinic populations compared.
  358. Reassessment of the metabolic effects of oral contraceptives [letter]
  359. Recent trends in contraceptive use.
  360. Recommendations for improving instructions for taking oral contraceptives.
  361. Regarding the preliminary paraclinical evaluation of oral contraception. [A propos du bilan paraclinique preliminaire a la contraception orale.]
  362. The relationship between family planning costs and contraceptive prevalence. Will FP costs per user decline over time?
  363. The relationship of service availability to contraceptive use in rural Guatemala.
  364. Relationships between contraceptive behavior and love attitudes, sex attitudes, and self-esteem.
  365. Reliability of oral contraceptives during long-time use of tetracycline for the treatment of acne. [Betrouwbaarheid van orale anticonceptiva tijdens langdurig gebruik van tetracycline ter behandeling van acne.]
  366. Report of the activity over 4 years of a family planning clinic within a public medical service. [Rapport sur l'activite d'une clinique de planification familiale, incorporee dans un service de medecine publique, pendant quatre annees.]
  367. Report of the final evaluation: Private Sector Midwives and Family Planning Project, Ghana.
  368. Report of the Workshop on Male Participation in Family Planning, Banjul, Gambia, 25-28 November 1991.
  369. Report on an assessment of the Eldoret CPK Community-Based Health / Family Planning Programme.
  370. Report on technical assistance provided to the Experiment in International Living - Proyecto de Apoyo a la Salud Materno Infantil (EIL - PAMI) component, expansion of family planning services, Guatemala.
  371. Report on the International Workshop on Family Planning Programmatic Research, August 28 - September 8, 1991, Bandung, Indonesia.
  372. Report on the study of interaction between clients and grass-root family planning workers: implications for programme performance.
  373. Report. Cost-effectiveness study. Ghana Family Planning Communications Project.
  374. Report. Seminar on Maternal and Child Health / Family Planning Programme Management, convened by the Regional Office for the Western Pacific of the World Health Organization, Nadi, Fiji, 29 April - 10 May 1991.
  375. Research on socio-cultural factors affecting family planning programmes in developing countries.
  376. Rethinking postpartum family planning.
  377. Revenue generation and sustainability activities of Family Planning Services Training Centre and its supported projects.
  378. Revenue generation and sustainability activities of the Family Planning Association of Bangladesh (FPAB)
  379. Review of family planning and health integration efforts and evaluation results.
  380. A review of the use of progestogen-only minipills for contraception during lactation.
  381. The right to family planning. [El derecho a la planificacion familiar.]
  382. Risk factors for acute myocardial infarction in Copenhagen. II: Smoking, alcohol intake, physical activity, obesity, oral contraception, diabetes, lipids, and blood pressure.
  383. Risk of breast cancer and oral contraceptives. [Mammakarzinomrisiko und orale Kontrazeptiva.]
  384. Risk of breast cancer in relation to use of combined oral contraceptives near the age of menopause.
  385. The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: a study of six patients.
  386. Role of phase IV trials in determining the safety and efficacy of oral contraceptives: guidelines for evaluation.
  387. The role of traditional organization on family planning acceptance in Indonesia.
  388. Role, status changes and family planning use among Cambodian refugee women.
  389. Romanian FPA (SECS) starts sexual and contraceptive consultations on the Black Sea coast.
  390. Rural women are using contraceptives.
  391. The rural-urban difference in contraceptive use in Pakistan: the effects of women's literacy and desired fertility.
  392. Santa Clara County health department Southeast Asian family planning needs assessment.
  393. Search for a male contraceptive: the effect of gossypol on sexual motivation and epididymal sperm.
  394. Seeking opportunities for natural family planning expansion: the Serena experience.
  395. Selected results concerning sexual behavior and contraceptive use from the 1988 National Survey of Family Growth and the 1988 National Survey of Adolescent Males.
  396. Selection of the sex of the child as a possible goal of family planning. [Volba pohlavi ditete jako mozny cil planovaneho rodicovstvi.]
  397. Self-esteem, erotophobia, and retention of contraceptive and AIDS information in the classroom.
  398. Semi-annual report: March 1, 1991 - August 31, 1991. Extending family planning services through Third World managers.
  399. Senegal project measures quality of interpersonal exchanges in family planning clinic.
  400. Seroprevalence of human immunodeficiency virus type I (HIV-1) antibodies in a family-planning population.
  401. Services availability and family planning in Egypt.
  402. Setting the stage for Fakube Jarra. A baseline survey of family planning knowledge, attitudes and practice in rural Gambia.
  403. Setting up a family planning clinic in general practice.
  404. Seventh International Meeting of the Society for Advancement of Contraception, Singapore, 4-11 November 1990.
  405. Sex and contraception among adolescent males.
  406. Sex education and family planning messages in Greek school books.
  407. Sex education, sex behavior, contraception. [Sexualaufklarung, Sexualverhalten, Kontrazeption.]
  408. Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
  409. Sex, contraception, and pregnancy among adolescents in Mexico City.
  410. Sexual activity and contraceptive use among low-income urban black adolescent females.
  411. Sexual activity, family life education and contraceptive practice among young men and women in greater Banjul, Gambia (1986-1987)
  412. The sexual and contraceptive socialization of black adolescent males (black adolescent sexuality)
  413. Sexual experience and contraception of young people in some Latin American countries. [Experiencia sexual y anticoncepcion en jovenes en algunos paises de America Latina.]
  414. Sexually transmitted disease treatment and return for test of cure of adolescents in a family planning clinic.
  415. Shanghai Municipal Family Planning Regulation, 1 August 1990.
  416. Sharing the challenge: establishing linkages between AIDS / STDs and family planning. Draft.
  417. Shortage of midwives -- the effect on family planning.

     

  418. Simplified approach to managing genital tract infections (GTIs) in family planning service programs.
  419. Single and multiple administration of a new triphasic oral contraceptive to women: pharmacokinetics of ethinyl estradiol and free and total testosterone levels in serum.
  420. A situation analysis of the family planning program of Zaire: a comparison of three service delivery systems.
  421. A situation analysis of the family planning program of Zaire: a comparison of three service delivery systems.
  422. A situation analysis of the Nairobi City Commission family planning clinics.
  423. The situation analysis study of the family planning program in Kenya.
  424. Situation paper: comparative bioavailability of oral contraceptive products.
  425. Situational analysis of family planning information, education, communication in Egypt.
  426. Smoking, the oral contraceptive pill, and Crohn's disease.
  427. Social aspects related to the introduction of a birth control vaccine.
  428. Social attitudes and family planning in rural Kenya [letter]
  429. A social learning model of adolescent contraceptive behavior.
  430. Social marketing in Honduras: impact on contraceptive prevalence and costs.
  431. Social mobility and family planning practices in rural Bangladesh -- a case study.
  432. Social preconditions of founding and developing the family planning movement. [Drustveni preduslovi osnivanja i razvoja pokreta planiranja porodice u svetu.]
  433. Social support and college student contraceptive use.
  434. Socioeconomic development, family planning, and fertility in Taiwan.
  435. Some examples of family planning programs. [Quelques exemples de programmes de planification familiale.]
  436. Some suggested future directions for A.I.D. family planning operations research.
  437. Son preference and contraception in Egypt.
  438. Soviet immigration in Israel: consequences for family planning and abortion services.
  439. Spanish adolescents: attitudes, knowledge and behaviour regarding contraceptive use.
  440. Spermicides for family planning and disease protection: an update.
  441. Sports injuries and oral contraceptive use. Is there a relationship.
  442. Statement on contraception for clients who are HIV positive.
  443. Statistical problems in family planning research.
  444. Statistics on population and family planning in China, 1988-1990.
  445. STD / AIDS prevention: new challenges for family planning programs.
  446. Strategic use of DHS data in family planning program development.
  447. Strategies for increased financial sustainablity by providers of health and family planning needs: the SMC experience of community-based sales pilot project.
  448. Strengthening collaborating institutions: the role of technical assistance in the family planning Operations Research Program.
  449. Strengthening family planning and health services through a study of their dynamics. The Indramayu Surveillance Registration System: project background, design and description as per October, 1991.
  450. Strengthening of management of maternal and child health and family planning programmes. Report of an intercountry workshop, New Delhi, 27-31 August 1990.
  451. Studies on blood coagulation and fibrinolysis during the use of oral contraceptives.
  452. Studies on the inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids. [Untersuchungen zur inter- und intraindividuellen Variabilitat pharmakokinetischer Parameter fur kontrazeptive Steroide.]
  453. Study cites unmet world demand for contraceptives..House panel votes to increase Pop Aid funding, rescind program restrictions.
  454. A study of a progestogen only oral contraceptive for lactating women in Khartoum, Sudan.
  455. A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
  456. A study of factors associated with contraceptive use dynamics in India (WHO sponsored study)
  457. Study of men's attitudes toward family planning and the implications for educational programs: the case of factory workers in Burkina Faso. [Etude des attitudes des hommes face a la planification familiale et les implications pour les programmes educatifs: le cas d'ouvriers d'usines au Burkina Faso.]
  458. Study on cytologic and colposcopic findings of the cervix after oral or vaginal use of combined contraceptive pills.
  459. A study on traditional contraception in Rwanda. [Etude sur la contraception traditionnelle au Rwanda.]
  460. Subdermal progestin implant contraception.
  461. A subdermal progestin implant for long-term contraception.
  462. Substrate and hormonal responses to exercise in women using oral contraceptives.
  463. In Sudan, fertility rates are high, but few plan to use contraceptives.
  464. Summaries of family planning operations research studies. Revised.
  465. Supervision of family planning activities.
  466. Supply aspects of meeting demand for family planning.
  467. Supreme Court ruling on family planning violates free speech, professional ethics.
  468. Survey of evaluation methods for family planning programs. [Apercu des methodes d'evaluation des programmes de planification familiale.]
  469. A survey to determine the knowledge, attitudes and practice of family planning amongst the nursing staff at Kenyatta National Hospital.
  470. Survival in breast cancer and age at start of oral contraceptive usage.
  471. Switching back: an experimental intervention of family planning client remotivation and clinic staff retraining: impact upon reacceptance and continuity.
  472. Tailoring family planning services to the special needs of adolescents.
  473. Tanzania Family Planning Communication Project baseline family planning audience survey, August - September, 1991.
  474. Tanzania Family Planning Communication Project. Report of technical assistance for research and evaluation for KAP survey and clinical studies.
  475. Tanzania Family Planning Communication Project: baseline family planning audience survey, August-September 1991.
  476. Targeting quality of care: a strategy for successful natural family planning services.
  477. A test of a model to predict and explain contraceptive use among adult multiparous females.
  478. Thirty years of hormonal contraception: an historical perspective.
  479. Three decades of hormonal contraception. Ethical considerations, legal limitations, risks and benefits. [Drei Jahrzehnte hormonale Kontrazeption. Ethische Erwagungen -- juristische Grenzen --Nutzen-Risiko-Bilanz.]
  480. Top-level push for China's family planning.
  481. Towards fewer laboratory tests before prescription of oral contraceptives in Africa? (letter) [Vers moins d'examens de laboratoire avant prescription de contraceptifs oraux en Afrique?]
  482. A tradition of choice: Planned Parenthood at 75.
  483. The traditional methods of contraception. [Traditsionnye metody kontratseptsii.]
  484. Training and supervision: from small natural family planning programs to national service delivery systems.
  485. Training evaluation: its impact on future instructor training, client education, and natural family planning services.
  486. Training of trainers in information education and communication for the family planning national training team, Abidjan, Cote d'Ivoire.
  487. Training: an international model for family planning providers.
  488. Translating concepts of total quality management to improve quality of health care in family planning service delivery programs in developing countries.
  489. Treatment of bleeding arteriovenous malformations with oral contraceptives: safe sex?
  490. Trends and determinants of contraceptive use in Kenya.
  491. Trends in contraception and sterilization in Australia.
  492. Trends in contraceptive method mix, continuation rates and failure rates in Matlab, Bangladesh: 1978-1987.
  493. Trends in the content and use of oral contraceptives in the United States, 1964-88.
  494. Trends in the contraceptive practices of women seeking abortions in the 1980s.
  495. Trip report: Tanzania. Monitoring the Family Planning Communication Project and designing the baseline KAP survey.
  496. Tubal sterilization, intrauterine contraception, and the risk of endometrial cancer.
  497. Tunisia: 26 years of family planning and still going strong.
  498. Twenty years of contraception in France: 1968-1988. [Vingt annees de contraception en France: 1968-1988.]
  499. A two-year audit of emergency contraception in a general practice.
  500. U.N. sees global fertility drop, birth control gains.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.